![Yuki Hasegawa](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yuki Hasegawa
Directeur/Bestuurslid bij NANO MRNA CO.,LTD.
Profiel
Yuki Hasegawa currently works at ActualEyes, Inc., as Director, NANO MRNA Co., Ltd., as Outside Director from 2021, and Whiz Partners, Inc., as Head-Healthcare Investment from 2021.
Actieve functies van Yuki Hasegawa
Bedrijven | Functie | Begin |
---|---|---|
NANO MRNA CO.,LTD. | Directeur/Bestuurslid | 01-06-2021 |
Whiz Partners, Inc.
![]() Whiz Partners, Inc. Investment ManagersFinance Whiz Partners, Inc. (Whiz Partners) is an independent venture capital firm headquartered in Tokyo, Japan. It became a separate entity from its former brand, CSK Venture Capital Co., Ltd. The firm was founded by Toshio Ando, Atsushi Matsumura, and Junichi Kajimoto in 2010. | Private Equity Investor | 01-01-2021 |
ActualEyes, Inc.
![]() ActualEyes, Inc. Packaged SoftwareTechnology Services ActualEyes, Inc. is a Japanese company that conducts research and development of products such as regenerative medicine for corneal endothelial disease. The company is based in Kyotanabe, Japan. The company's mission is to deliver the desired light to patients suffering from visual impairment and to ensure and promptly implement a new treatment society. The company was founded in 2018. The CEO is Iku Sugioka. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
NANO MRNA CO.,LTD. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Whiz Partners, Inc.
![]() Whiz Partners, Inc. Investment ManagersFinance Whiz Partners, Inc. (Whiz Partners) is an independent venture capital firm headquartered in Tokyo, Japan. It became a separate entity from its former brand, CSK Venture Capital Co., Ltd. The firm was founded by Toshio Ando, Atsushi Matsumura, and Junichi Kajimoto in 2010. | Finance |
ActualEyes, Inc.
![]() ActualEyes, Inc. Packaged SoftwareTechnology Services ActualEyes, Inc. is a Japanese company that conducts research and development of products such as regenerative medicine for corneal endothelial disease. The company is based in Kyotanabe, Japan. The company's mission is to deliver the desired light to patients suffering from visual impairment and to ensure and promptly implement a new treatment society. The company was founded in 2018. The CEO is Iku Sugioka. | Technology Services |